Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report

Fig. 2

Axial (a) T2-weighted FLAIR MRI under clinical relapse showing multiple new supratentorial lesions; axial (b) T1-weighted images showing lesions with ring gadolinium-enhancement, (c) sagittal T2-weighted FLAIR MRI showing different spinal cord lesions, one of them with ring gadolinium-enhancement on T1-SPIR weighted image. (d), (e), (f) are the same images repeated after 40 days from high dose of steroids i.v.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us